Genomic Underpinnings of Tumor Behavior in in situ and Early Lung Adenocarcinoma.
Our understanding of the molecular underpinnings of early adenocarcinoma (ADC) progression remains limited. We hypothesized that the behavior of early ADC can be predicted based on genomic underpinnings. Objectives：To identify genomic alterations associated with resected indolent and aggressive early lung ADCs. DNA was extracted from 21 adenocarcinoma in situ (AIS), 27 minimally invasive adenocarcinoma (MIA) and 54 fully invasive adenocarcinoma and subjected to deep next generation sequencing to target a custom 347 cancer gene panel. The association between tumor mutation burden, frequencies of mutation and copy number alterations, mutation signatures, intratumor heterogeneity, pathway alterations and histology as well as overall survival were performed. We found deleterious mutation burden was significantly greater in invasive ADC. Intratumor heterogeneity occurs as early as in AIS. More copy number loss was observed in AIS/MIA. Twenty-one significantly mutated genes were shared among three groups. Mutation signature profiling had no significant difference among three groups, although APOBEC signature was associated with ADC subgroup and poor survival. Mutations of KRAS, TP53 and NF1 were found at an increasing frequency from AIS/MIA to ADC. A cancer progression model revealed selective early and late drivers. Subclonal KRAS mutations and a gene signature consisting of PIK3CG, ATM, EPPK1, EP300 or KMT2C mutations were associated with poor survival. Our results demonstrate several sequences of genetic driver events, gene clonality and mutated gene signatures associated with outcome in early lung ADC with potential future implications in the management of early ADC.